180 likes | 368 Views
Renub Research (http://www.renub.com/report/united-states-pediatric-vaccines-market-doses-immunization-vaccinated-cases-forecast-165) has announced the addition of the "United States Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast" report to its offering
E N D
Table of Contents Executive Summary United States – Pediatric Vaccines Market & Forecast United States – Pediatric Vaccines Market Share & Forecast 4. United States – Pediatric Vaccines Cases, Doses, Immunization Coverage, Market & Forecast 4.1 United States – Measles, Mumps & Rubella (MMR) Vaccines & Forecast 4.1.1 Number of Measles, Mumps & Rubella (MMR) Cases 4.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses
Continue (www.renub.com) 4.1.3 Measles, Mumps & Rubella (MMR) – Number of Children Being Vaccinated 4.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines 4.2 United States – HaemophilusInfluenzae Type B (HIB) Vaccines & Forecast 4.2.1 Number of HaemophilusInfluenzae Type B (HIB) Vaccines Doses 4.2.2 HaemophilusInfluenzae Type B (HIB) – Number of Children Being Vaccinated 4.2.3 Market Size of HaemophilusInfluenzae Type B (HIB) Vaccines
Continue (www.renub.com) 4.3 United States – Polio Vaccines & Forecast 4.3.1 Number of Polio Cases 4.3.2 Number of Polio Vaccines Doses 4.3.3 Polio Vaccines – Number of Children Being Vaccinated 4.3.4 Market Size of Polio Vaccines 4.4 United States – Diphtheria, Tetanus & Pertussis (DTap) Vaccines & Forecast 4.4.1 Number of Diphtheria, Tetanus & Pertussis (DTaP) Cases 4.4.2 Number of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Doses
Continue (www.renub.com) 4.4.3 Diphtheria, Tetanus & Pertusis (DTaP) – Number of Children Being Vaccinated 4.4.4 Market Size of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines 4.5 United States – Pneumococcal Vaccines & Forecast 4.5.1 Number of Pneumococcal Vaccines Doses 4.5.2 Pneumococcal – Number of Children Being Vaccinated 4.5.3 Market Size of Pneumococcal Vaccines 4.6 United States – Rotavirus Vaccines & Forecast 4.6.1 Number of Rotavirus Vaccines Doses
Continue (www.renub.com) 4.6.2 Rotavirus – Number of Children Being Vaccinated 4.6.3 Market Size of Rotavirus Vaccine 4.7 United States – Hepatitis B Pediatric Vaccines & Forecast 4.7.1 Number of Hepatitis B Pediatric Vaccines Doses 4.7.2 Hepatitis B Pediatric – Number of Children Being Vaccinated 4.7.3 Market Size of Hepatitis B Pediatric Vaccines
Continue (www.renub.com) 4.8 United States – Hepatitis A Pediatric Vaccines & Forecast 4.8.1 Number of Hepatitis A Pediatric Vaccines Doses 4.8.2 Hepatitis A Pediatric – Number of Children Being Vaccinated & Forecast 4.8.3 Market Size of Hepatitis A Pediatric Vaccines 4.9 United States – Varicella / Chicken Pox Vaccines & Forecast 4.9.1 Number of Varicella / Chicken Pox Vaccines Doses 4.9.2 Varicella/Chicken Pox – Number of Children Being Vaccinated 4.9.3 Market Size of Varicella/Chicken Pox Vaccines
Continue (www.renub.com) 4.10 United States – Influenza Pediatric Vaccines & Forecast 4.10.1 Number of Influenza Pediatric Vaccines Doses 4.10.2 Influenza Pediatric Vaccines – Number of Children Being Vaccinated 4.10.3 Market Size of Influenza Pediatric Vaccines 5. Growth Drivers of United States Pediatric Vaccines Market 5.1 Increase Immunization Rates & Reduce Preventable Infectious Diseases 5.2 Increasing Vaccine Availability in United States 5.3 The Vaccine Safety Data link Project
Continue (www.renub.com) 5.4 The Vaccine Injury Compensation Program 5.5 Transforming of Vaccine Technologies 5.6 Continuous Focus on Effective Communication Strategies 6. Challenges of United States Pediatric Vaccines Market 6.1 Impediment in Pediatric Vaccine Research & Development 6.2 Barriers to New Entrants in the Pediatric Vaccines Market 6.3 Hurdles to Optimal use of Licensed Vaccines 6.3.1 Technical Obstacles 6.3.2 Economic obstacles
Continue (www.renub.com) 6.3.3 Cultural Obstacles 6.4 Complexity of Vaccine Development & Approval System Thwarts Product Development 6.4.1 Legal Obstacles 6.4.2 General Technical Barriers 6.4.3 Economic Barriers 6.4.4 Regulatory Barriers 6.5 Shortening the Timeline for Vaccine Development
Continue (www.renub.com) 6.6 Refusal / Resistance to Vaccination 6.6.1 Vaccine Adverse Event Reporting System 6.7 Vaccine Shortages and Delays 6.8 Emerging Issues in Immunization and Infectious Diseases in United States
Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
Order Form • Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. • Questions? Please call • +1-678-302-0700 (USA) • +91-120-421-9822 (India), ,+91-120-424-9780 • or mail to info@renub.com
Format Report Title: United States Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast For More Details: http://www.renub.com/report/united-states-pediatric-vaccines-market-doses-immunization-vaccinated-cases-forecast-165
For ordering this report: Three easy ways to place your order 1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/buyreport/165-1630 2) Order by Wire Transfer: http://www.renub.com/report/wiretransfer.aspx?id=165&pid=1630 To pay by Wire Transfer, please, fill in your contact details in the form below:
Bank Details Account Name:Renub Research A/C No.:109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code:IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India
Contact Information First Name: Last Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:
Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1st Floor, C-86, Sector-10 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780 For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)